Rosuvastatin: a review of the pharmacology and clinical effectiveness in cardiovascular disease.
about
Impact of treatment with rosuvastatin and atorvastatin on cardiovascular outcomes: evidence from the Archimedes-simulated clinical trialsLipid management in India: a nationwide, cross-sectional physician survey.Comparison of the efficacy of rosuvastatin versus atorvastatin in preventing contrast induced nephropathy in patient with chronic kidney disease undergoing percutaneous coronary intervention.Rosuvastatin attenuates contrast-induced nephropathy through modulation of nitric oxide, inflammatory responses, oxidative stress and apoptosis in diabetic male ratsEffect of rosuvastatin on arginase enzyme activity and polyamine production in experimental breast cancer.Doctors' knowledge, attitudes, and compliance with 2013 ACC/AHA guidelines for prevention of atherosclerotic cardiovascular disease in Singapore.Factors of compliance in patients with hypercholesterolemia using rosuvastatin in primary care.Impact of combined treatment with rosuvastatin and antidepressants on liver and kidney function in ratsA phase I study of high-dose rosuvastatin with standard dose erlotinib in patients with advanced solid malignanciesCurrent Perspectives on rosuvastatin.Pediatric pharmacogenomics: a systematic assessment of ontogeny and genetic variation to guide the design of statin studies in children.Shear-Sensitive Genes in Aortic Valve Endothelium.The renoprotective effects of simvastatin and atorvastatin in patients with acute coronary syndrome undergoing percutaneous coronary intervention: An observational study.Efficacy comparison of atorvastatin versus rosuvastatin on blood lipid and microinflammatory state in maintenance hemodialysis patients.Effect of Rosuvastatin on Acute Kidney Injury in Sepsis-Associated Acute Respiratory Distress Syndrome
P2860
Q26776293-7E3B37FF-3377-4433-B352-0D88B4C17816Q33868780-B4B4CEDE-E917-43D0-8988-275A9381B860Q34428322-D0AA45F5-9290-4A32-821D-5E850AA7C857Q35085628-5D72F9F1-EB07-46C1-A647-CD12A812AC58Q35125507-1A76ED39-5A8A-42B2-A688-0E29952E2702Q35702827-C267651A-4EB5-4FB5-9D5F-26E692EE75ACQ36346866-DD44E898-C47F-4FBB-9E3E-517E2A43C807Q36741741-0EDB4B2D-F6A2-4C96-9470-CB5EE768171CQ36748775-39C98A10-70B7-4EDE-A092-99EDF4B8DD55Q36796490-E303527D-C1CB-4DBC-9E63-3BB6EA656962Q38049379-E9C21EDF-5811-414E-A3B3-F0E2AC7E089DQ38664184-B0865CED-5A46-4FF3-90D5-9487D47794F9Q40088029-4BBEB96D-B949-4AD1-8657-F3F160038ADBQ51326088-4AD189FF-2ED4-4D4F-9EA6-C05B4C0652B9Q58803298-1745573A-101C-478B-9DB0-25775026D61A
P2860
Rosuvastatin: a review of the pharmacology and clinical effectiveness in cardiovascular disease.
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Rosuvastatin: a review of the ...... ess in cardiovascular disease.
@ast
Rosuvastatin: a review of the ...... ess in cardiovascular disease.
@en
Rosuvastatin: a review of the ...... ess in cardiovascular disease.
@en-gb
Rosuvastatin: a review of the ...... ess in cardiovascular disease.
@nl
type
label
Rosuvastatin: a review of the ...... ess in cardiovascular disease.
@ast
Rosuvastatin: a review of the ...... ess in cardiovascular disease.
@en
Rosuvastatin: a review of the ...... ess in cardiovascular disease.
@en-gb
Rosuvastatin: a review of the ...... ess in cardiovascular disease.
@nl
prefLabel
Rosuvastatin: a review of the ...... ess in cardiovascular disease.
@ast
Rosuvastatin: a review of the ...... ess in cardiovascular disease.
@en
Rosuvastatin: a review of the ...... ess in cardiovascular disease.
@en-gb
Rosuvastatin: a review of the ...... ess in cardiovascular disease.
@nl
P2093
P2860
P356
P1476
Rosuvastatin: a review of the ...... ess in cardiovascular disease.
@en
P2093
Ahai Luvai
Julian H Barth
Wycliffe Mbagaya
P2860
P356
10.4137/CMC.S4324
P577
2012-02-01T00:00:00Z